CVE-2019-19217

Name: CVE-2019-19217
Creator: NVD / NIST
Published: 2020-04-30T14:15:12.433+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

HIGHCVSS 8.8/10EPSS 1.81%

Last modified Jun 17, 2026

CVE-2019-19217 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. BMC Control-M/Agent 7.0.00.000 allows OS Command Injection.. EPSS estimates a 1.81% chance of exploitation in the next 30 days.

Description

BMC Control-M/Agent 7.0.00.000 allows OS Command Injection.

Metrics

CVSS 3.1

8.8/10

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

EPSS Probability

1.81%

75.9th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-78

Affected Software

Vendor	Product	Versions
Bmcsoftware	Control-M\/Agent	7.0.00.000

References

https://herolab.usd.de/security-advisories/usd-2019-0059/Third Party Advisory
https://herolab.usd.de/security-advisories/usd-2019-0059/Third Party Advisory

Timeline

Published: Apr 30, 2020
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2019-19217?

BMC Control-M/Agent 7.0.00.000 allows OS Command Injection.

How severe is CVE-2019-19217?

CVE-2019-19217 has a CVSS score of 8.8/10 (HIGH severity). The EPSS model estimates a 1.81% probability of exploitation in the next 30 days.

How do I fix CVE-2019-19217?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2019-19217?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST